NOTCH3 and ovarian carcinoma: Results from the present study demonstrate that MSeA can synergistically enhance the efficacy of carboplatin in the killing of OVCA429/NICD3 ovarian cancer cells, suggesting a new strategy to treatment of high grade ovarian carcinoma exhibiting Notch3 activation.